{"id":"W2897631076","doi":"10.1093/annonc/mdy374.041","title":"A phase I trial of BI 754091, a programmed death receptor 1 (PD-1) inhibitor, in patients with advanced solid tumors","year":2018,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Boehringer Ingelheim (Canada); Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Tolerability; Adverse effect; Pharmacokinetics; Internal medicine; Oncology; Cancer; Pharmacology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009007839,0.00162059,0.001389364,0.0003871663,0.0004251328,0.000984556,0.0007030797,0.000777987,0.00346939],"category_scores_gemma":[0.0005389526,0.000468069,0.0006395378,0.0004525336,0.000889323,0.0007326936,0.0003963558,0.002464361,0.0009932138],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001068731,"about_ca_system_score_gemma":0.001829859,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001487726,"about_ca_topic_score_gemma":0.002702935,"domain_scores_codex":[0.9997285,0.00009328638,0.00001452774,0.00005484918,0.00002819143,0.00008052985],"domain_scores_gemma":[0.9995901,0.00004209383,0.00006563446,0.00002928803,0.00001857488,0.0002542569],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7015331,0.07980203,0.01083217,0.000755024,0.0009009945,0.0005952831,0.0006468245,0.005280522,0.06433008,0.0007045686,0.006879198,0.1277401],"study_design_scores_gemma":[0.4652646,0.5077647,0.01528278,0.00003296917,0.0003516416,0.0004369916,0.00008091969,0.001834798,0.004889285,0.0003154748,0.00371902,0.00002691437],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933171,0.0009207797,0.0003764527,0.0003285728,0.00005983642,0.001976952,0.0007612216,0.00008291507,0.00217611],"genre_scores_gemma":[0.9923056,0.0007636113,0.001267934,0.0005032573,0.00008338274,0.001450734,0.001648554,0.00001830224,0.001958719],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00346939,"threshold_uncertainty_score":0.01160622,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05004048888174779,"score_gpt":0.3987737596194499,"score_spread":0.3487332707377022,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}